These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 4944989)

  • 1. Preparation and properties of antisera against the lipid-A component of bacterial lipopolysaccharides.
    Galanos C; Lüderitz O; Westphal O
    Eur J Biochem; 1971 Dec; 24(1):116-22. PubMed ID: 4944989
    [No Abstract]   [Full Text] [Related]  

  • 2. The lipid A immunity system. I. Induction of heterophile antibodies by enterobacterial lipopolysaccharides and their lipid A component.
    Rank WR; DiPauli R; Flügge-Rank U
    Eur J Immunol; 1972 Dec; 2(6):517-22. PubMed ID: 4569996
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection and specificity of lipid A antibodies using liposomes sensitized with lipid A and bacterial lipopolysaccharides.
    Kataoka T; Inouse K; Galanos C; Kinsky SC
    Eur J Biochem; 1971 Dec; 24(1):123-7. PubMed ID: 5167719
    [No Abstract]   [Full Text] [Related]  

  • 4. Crossreactions of Escherichia coli K and O polysaccharides in antipneumococcal and anti-Salmonella sera.
    Heidelberger M; Jann K; Jann B
    J Exp Med; 1985 Oct; 162(4):1350-8. PubMed ID: 3900268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of the first (C1), the second (C2) and the fourth (C4) component of complement with different preparations of bacterial lipopolysaccharides and with lipid A.
    Loos M; Bitter-Suermann D; Dierich M
    J Immunol; 1974 Mar; 112(3):935-40. PubMed ID: 4590707
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunization with R mutants of S. Minnesota. I. Protection against challenge with heterologous gram-negative bacilli.
    McCabe WR
    J Immunol; 1972 Mar; 108(3):601-10. PubMed ID: 4622185
    [No Abstract]   [Full Text] [Related]  

  • 7. [Infant enteritis due to coli. 3. Immune properties of enteropathogenic Coli-O-strains].
    Metz H
    Zentralbl Bakteriol Orig A; 1972 Apr; 219(4):452-8. PubMed ID: 4145479
    [No Abstract]   [Full Text] [Related]  

  • 8. An Escherichia coli antigen cross-reactive with the capsular polysaccharide of Haemophilus influenzae type b: occurrence among known serotypes, and immunochemical and biologic properties of E. coli antisera toward H. influenzae type b.
    Schneerson R; Bradshaw M; Whisnant JK; Myerowitz RL; Parke JC; Robbins JB
    J Immunol; 1972 Jun; 108(6):1551-62. PubMed ID: 4624175
    [No Abstract]   [Full Text] [Related]  

  • 9. Heterogeneity of the haemagglutinin responses to Salmonella minnesota R-antigens in rabbits.
    Nixdorff KK; Schlecht S
    J Gen Microbiol; 1972 Aug; 71(3):425-40. PubMed ID: 4647468
    [No Abstract]   [Full Text] [Related]  

  • 10. Complement activation in relation to protective function of antibodies to Escherichia coli O antigens.
    Ahlstedt S; Hanson LA
    Scand J Immunol; 1975 Sep; 4(5-6):511-5. PubMed ID: 1101368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on hemagglutination and hemolysis by escherichia coli antisera.
    NETER E; BERTRAM LF; ZAK DA; MURDOCK MR; ARBESMAN CE
    J Exp Med; 1952 Jul; 96(1):1-15. PubMed ID: 14946324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of anti-HL-A alloantisera by glycoproteins, polysaccharides, and lipopolysaccharides from diverse sources.
    Mittal KK; Terasaki PI; Springer GF; Desai PR; McIntire FC; Hirata AA
    Transplant Proc; 1973 Mar; 5(1):499-506. PubMed ID: 4572110
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential effects on immunogenicity and antigenicity of heat, freezing and alkali treatment of bacterial antigens.
    Whang HY; Mayer H; Neter E
    J Immunol; 1971 Jun; 106(6):1552-8. PubMed ID: 4253536
    [No Abstract]   [Full Text] [Related]  

  • 14. Modulation of in vivo antibody responses by cholera toxin.
    Kateley JR; Kasarov L; Friedman H
    J Immunol; 1975 Jan; 114(1 Pt 1):81-4. PubMed ID: 163279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with R mutants of Salmonella minnesota. II. Serological response to lipid A and the lipopolysaccharide of Re mutants.
    Johns MA; Bruins SC; McCabe WR
    Infect Immun; 1977 Jul; 17(1):9-15. PubMed ID: 69613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to core lipopolysaccharide determinants: absence of cross-reactivity with heterologous lipopolysaccharides.
    Heumann D; Baumgartner JD; Jacot-Guillarmod H; Glauser MP
    J Infect Dis; 1991 Apr; 163(4):762-8. PubMed ID: 1707084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective capacity of antibodies against E. coli O antigen with special reference to the avidity.
    Ahlstedt S; Holmgren J; Hanson LA
    Int Arch Allergy Appl Immunol; 1974; 46(3):470-80. PubMed ID: 4607906
    [No Abstract]   [Full Text] [Related]  

  • 18. Amount, class and specificity of antibody to the lipopolysaccharide of Salmonella enteritidis after immunization by various schedules.
    Gupta JD; Reed CE
    Int Arch Allergy Appl Immunol; 1971; 40(2):256-63. PubMed ID: 4993854
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential antibody response to the somatic antigenic determinants of Rhizobium trifolii.
    Humphrey B; Vincent JM
    Microbios; 1973; 7(26):87-93. PubMed ID: 4132099
    [No Abstract]   [Full Text] [Related]  

  • 20. [Demonstration of antibodies to salmonella-R-antigens in salmonella-O-antisera].
    Schlecht S; Böhlck I; Westphal O
    Zentralbl Bakteriol Orig; 1971; 216(4):472-82. PubMed ID: 5104309
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.